Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut morbi tincidunt augue interdum velit euismod in pellentesque massa. Neque egestas congue quisque egestas diam in .Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
TUCSON, Ariz., June 7, 2022 — Critical Path Institute (C-Path) and MitoAction today announced a joint collaboration to incorporate...
Read MoreFOR RELEASE FRIDAY, FEB. 4 AT 11:30AM TK2d Patient Voices Elevated at FDA United Mitochondrial Disease Foundation, MitoAction Champion...
Read MoreThis partnership will support multiple Leigh syndrome research projects and fuel development of future treatments. September 19, 2020 —...
Read MoreMitoAction announces the appointment of three members to the board of directors. Each new member brings an array of...
Read MoreJustina Pelletier was 14 in 2013 when she landed in a locked psychiatric unit at Boston Children’s Hospital, temporarily a ward...
Read MoreATLANTA, January 8, 2018 — The Foundation for Mitochondrial Medicine (FMM), MitoAction, the Mitochondrial Medicine Society (MMS) and the...
Read MoreMitoAction has joined Patients and Physicians for Rx Access, a coalition addressing the issue of insurance cuts to compounded...
Read MoreABC’s Extreme Home Makeover & the Boston Bruins Foundation work with MitoAction for the makeover of the Tufts Medical...
Read MoreMitochondrial Disease Action Committee (MitoAction) Statement on Autism, Vaccines and Mitochondrial Disease www.MitoAction.org March 21, 2008 The recent headlines...
Read MoreIt is with great pride and sincerity that I ask all members, families and friends of MitoAction to please...
Read MoreOnce in a while, you get a great opportunity. Today, we are really excited to show off our new...
Read MoreMitochondrial Disease Leadership Creed for Physicians, Researchers, Patient Advocates and Organization Representatives We believe that mitochondrial disease is a...
Read MoreIn the past year, the mitochondrial disease community has witnessed the closing of five clinics specializing in the treatment...
Read MoreOn Monday, July 20, 2015, MitoAction submitted a comment to the FDA on its proposed Memorandum of Understanding concerning...
Read MoreJune 12, 2018 (Boston, MA) – MitoAction (www.mitoaction.org), a leading patient advocacy organization within the mitochondrial disease community and...
Read MoreMannie Taimuty-Loomis, MA, LBS and Executive Director of the Jonah & The Whale Foundation, Inc. to learn more and...
Read More